Withings Scanwatch Nova – Heart Health Hybrid Smart Watch for Men & Women – SPO2, Temperature Monitoring, Sleep, Respiratory Health, Cycle Monitoring, 30-Day Battery Life, Apple iOS/Android
$591.47





Price: $591.47
(as of Mar 31, 2025 09:09:19 UTC – Details)
ScanWatch is now available in a limited edition that combines iconic diver watch design with breakthrough health tech. Nested in a high-end watch, state-of-the-art medical technology has been carefully selected to create the most health-oriented watch ever offered to the public.
HEART RATE TRACKING – Monitor heart rate to optimize workouts, 24/7 tracking with notifications if heart rate is too high or too low, and overnight heart rate variability to track health over time.
MENSTRUAL CYCLE GUIDE – This smartwatch is great for women to log cycle phases, period duration, period symptoms, flow and moods over time to create a personalized routine to align with your needs.*
ADVANCED 24/7 ACTIVITY TRACKING – 40+ activities recognized with heart rate zones during workout, Fitness Level via VO2 max and connected GPS tracker. Track your trends to improve your performance.
SLEEP TRACKER – Wake up to your Sleep Quality Score, improve your energy levels with insight into your sleep metrics: light sleep, deep sleep, duration, disturbances, interruptions and regularity.
30-DAY BATTERY & EXTRA DURABILITY – Enjoy 24/7 tracking for up to 30 days on a single charge, comes with docking station, USB-C compatible. Made with premium materials for extra durability.
Customers say
Customers find the smartwatch gorgeous and solid in quality. They appreciate its comfort and ease of use, with one customer noting it’s easy to set up notifications. They like its features, with one highlighting its excellent heart monitoring capabilities.
User Reviews
Be the first to review “Withings Scanwatch Nova – Heart Health Hybrid Smart Watch for Men & Women – SPO2, Temperature Monitoring, Sleep, Respiratory Health, Cycle Monitoring, 30-Day Battery Life, Apple iOS/Android”
$591.47
There are no reviews yet.